In the xenotransplantation model of ER-positive breast cancer derived from patients, palbociclib plus anti-estrogen letrozole (compared with any drug alone) has a greater inhibitory effect on Rb phosphorylation, downstream signal transduction, and tumor growth [25]. The gene discussed is RB1; the disease is neoplasm.